MARKET

ANEB

ANEB

Anebulo Pharmaceuticals Inc
NASDAQ
1.120
+0.010
+0.90%
After Hours: 1.120 0 0.00% 16:04 05/23 EDT
OPEN
1.100
PREV CLOSE
1.110
HIGH
1.120
LOW
1.090
VOLUME
4.28K
TURNOVER
--
52 WEEK HIGH
3.080
52 WEEK LOW
0.8001
MARKET CAP
46.01M
P/E (TTM)
-4.1854
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Waters (WAT) and Anebulo Pharmaceuticals (ANEB)
TipRanks · 2d ago
ANEBULO PHARMACEUTICALS INC <ANEB.O>: BENCHMARK CUTS TARGET PRICE TO $3 FROM $8
Reuters · 2d ago
Weekly Report: what happened at ANEB last week (0512-0516)?
Weekly Report · 5d ago
Anebulo Pharmaceuticals Price Target Cut to $3.00/Share From $6.00 by Maxim Group
Dow Jones · 05/15 17:24
Anebulo Pharmaceuticals Is Maintained at Buy by Maxim Group
Dow Jones · 05/15 17:24
Maxim Group Maintains Buy on Anebulo Pharmaceuticals, Lowers Price Target to $3
Benzinga · 05/15 17:14
Anebulo Pharmaceuticals price target lowered to $3 from $6 at Maxim
TipRanks · 05/15 12:21
Anebulo Pharmaceuticals Focuses on Pediatric Cannabis Toxicity Treatment
TipRanks · 05/15 04:20
More
About ANEB
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company. It is engaged in developing treatments for cannabis toxicity, such as unintentional cannabis poisoning, acute cannabinoid intoxication (ACI) and the landscape of acute cannabis-induced conditions. Its lead product candidate is selonabant, a potent, small molecule antagonist of cannabinoid binding receptor type-1 (CB1), the primary receptor involved in the psychotropic effects of cannabinoids, with the potential to address the unmet medical need for a therapy to treat cannabis toxicity. Selonabant is orally bioavailable, rapidly absorbed, and has also been formulated for intravenous administration. Selonabant is intended to rapidly reverse the negative effects of cannabis-induced toxicity and reduce time to recovery. It is also prioritizing the advancement of a selonabant intravenous (IV) formulation as a potential treatment for pediatric patients with cannabis-induced CNS depression.

Webull offers Anebulo Pharmaceuticals Inc stock information, including NASDAQ: ANEB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANEB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANEB stock methods without spending real money on the virtual paper trading platform.